| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.025 | 0.7 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.067 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.093 | 0.2 |